查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1446562

生命科學 MES（製造執行系統）市場規模、佔有率、趨勢分析報告：按解決方案類型、部署、最終用戶、地區和細分市場預測，2024-2030 年

Manufacturing Execution System in Life Sciences Market Size, Share & Trends Analysis Report By Solution Type, By Deployment (On-Premise, Cloud/Web-Based, Hybrid), By End-User, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

生命科學的 MES（製造執行系統）市場成長與趨勢：

Grand View Research, Inc. 的最新報告顯示，生命科學 MES 的全球市場規模預計到 2030 年將達到 60 億美元，2024 年至 2030 年複合年成長率為 12.2%。

MES 的實施已成為生命科學產業的關鍵要素，有助於提高整個生產過程的效率、合規性和創新性。在北美，MES 在生命科學領域的採用正在迅速增加，凸顯了其對製造工作流程的變革性影響。製藥和生物技術等生命科學產業需要複雜的製造管理方法。 MES 提供整合的、資料主導的解決方案，在滿足和超越監管要求、降低風險和確保產品品質方面發揮關鍵作用。

生命科學製造對精度和品質的需求不斷成長是市場成長的關鍵驅動力。 MES 可讓您最佳化製造工作流程、最大限度地減少錯誤並保持產品開發的一致性。隨著業界轉向個人化醫療和創新治療方法，MES 的彈性和敏捷性尤其有價值。此外，工業 4.0 技術的興起正在推動 MES 的採用。與物聯網 (IoT) 和分析的集合成為生命科學製造商創建了智慧製造生態系統。這種連接可以實現即時監控、控制和資料主導的決策，從而提高業務效率。對生產力、縮短時間和卓越的產品品質日益成長的需求正在推動 MES 在生命科學產業的採用。 MES 正在成為現代製造業追求無縫、互聯和技術先進的未來的中心樞紐。

生命科學 MES 市場報告亮點

  • 由於對無紙化製造的高需求、製造流程向數位化和自動化的轉變，軟體解決方案類型細分市場在 2023 年佔據最大佔有率。
  • 預計本地部署細分市場將在 2023 年佔據最大佔有率，並在 2024 年至 2030 年期間以 11.7% 的複合年成長率成長。本地MES系統易於在本地儲存資料，且不依賴繁重的網際網路來不間斷通訊。
  • 這些因素正在推動市場的採用。同時，基於雲端/網路的部署領域預計將從 2024 年到 2030 年以 13.0% 的複合年成長率成長最快。
  • 2023年，製藥和生技公司的最終用戶部分佔最大佔有率，達到48.4%。這可以歸因於自動化和數位化趨勢導致該領域 MES 的高採用率。
  • 由於艾默生電氣公司、羅克韋爾自動化和西門子公司等主要參與者的存在，北美在 2023 年以 31.0% 的佔有率主導全球市場。預計 2024 年至 2030 年，亞太地區將以最快的複合年成長率成長。
  • 主要參與者正在採取產品開發、合作、併購等各種策略，這正在推動市場競爭。
  • 例如，2023 年 9 月，Korber 和 Endeavor 合作促進 Werum PAS-X MES 與 SAP ERP 平台的整合。此次合作旨在為使用這兩種軟體解決方案進行業務的企業提供無縫解決方案。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第 3 章生命科學 MES 市場：變數、趨勢、範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 生命科學 MES 市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章生命科學MES市場：解決方案類型的估算與趨勢分析

  • 定義和範圍
  • 細分儀表板
  • 生命科學MES市場波動分析
  • 2018-2030 年生命科學 MES 市場規模和趨勢分析（按解決方案類型）

第5章生命科學MES市場：發展預估與趨勢分析

  • 定義和範圍
  • 細分儀表板
  • 生命科學MES市場波動分析
  • 2018-2030 年生命科學 MES 市場規模與趨勢分析（按部署）

第6章生命科學MES市場：最終用戶估計與趨勢分析

  • 定義和範圍
  • 細分儀表板
  • 生命科學MES市場波動分析
  • 2018-2030 年生命科學 MES 市場規模與趨勢分析（按最終用戶）

第 7 章生命科學 MES 市場：按解決方案類型、部署和最終用戶分類的區域估計和趨勢分析

  • 區域市場儀表板
  • 全球區域市場概述
  • 2018-2030年市場規模及預測趨勢分析
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第8章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司/競爭對手分類
    • 創新者
  • 供應商形勢
    • ABB
    • Korber AG
    • MasterControl Solutions, Inc.
    • AVEVA Group Limited
    • Cognizant
    • Rockwell Automation
    • nagarro
    • Siemens AG
    • Emerson Electric Co.
    • iBase-t
Product Code: GVR-4-68040-206-3

Manufacturing Execution System in Life Sciences Market Growth & Trends:

The global manufacturing execution system in life sciences market size is anticipated to reach USD 6.0 billion by 2030, registering a CAGR of 12.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The adoption of manufacturing execution system (MES) is emerging as a key factor in the life science industry, helping to improve efficiency, compliance, and innovation across production processes. In North America, MES implementation is experiencing a significant surge in the life science sector, highlighting its transformative impact on manufacturing workflows. Life science industries, including pharmaceuticals and biotechnology, require a sophisticated approach to manufacturing management. MES provides integrated and data-driven solutions that are instrumental in meeting and exceeding regulatory requirements, reducing risks, and ensuring product quality.

The growing demand for precision and quality in life science manufacturing is a key driver of market growth. MES enables companies to optimize production workflows, minimize errors, and maintain consistency in product development. Its flexibility and agility are especially valuable as the industry shifts toward personalized medicine and innovative therapies. Moreover, the prominence of Industry 4.0 technologies has bolstered the adoption of MES. Integration with the Internet of Things (IoT) and analytics creates an intelligent manufacturing ecosystem for life science manufacturers. This connectivity enables real-time monitoring, control, and data-driven decision-making, enhancing operational efficiency. Increasing demand for productivity, faster time-to-market, and superior product quality boost the adoption of MES in the life science industry. MES is becoming a central hub in the pursuit of a seamless, interconnected, and technologically advanced future in modern manufacturing.

Manufacturing Execution System in Life Sciences Market Report Highlights:

  • The software solution type segment held the largest share in 2023 due to the high demand for paperless manufacturing, shift towards digitalization, and automation in manufacturing processes
  • The on-premise deployment segment held the largest share in 2023 and is expected to grow at a CAGR of 11.7% from 2024 to 2030. The on-premise MES system offers ease of storing data on premises and does not rely on heavy internet, which will not hamper communication
  • Such factors drive its adoption in the market. On the other hand, the cloud/web-based deployment segment is expected to grow at the fastest CAGR of 13.0% from 2024 to 2030
  • The pharmaceutical & biotechnology companies end-use segment held the largest share of 48.4% in 2023. This can be attributed to the high adoption of MES in this segment owing to the shifting trend towards automation and digitalization
  • North America dominated the global market with a share of 31.0% in 2023 owing to the presence of key players including Emerson Electric Co., Rockwell Automation, and Siemens AG. Asia Pacific is expected to grow at the fastest CAGR from 2024 to 2030
  • Various strategies, such as product development, partnerships, and mergers & acquisitions, are adopted by key players, which is driving the market competition
  • For instance, in September 2023, Korber and Endeavor partnered to facilitate the integration of Werum PAS-X MES with SAP's ERP platform. This partnership aims to provide a seamless solution for businesses that use these two software solutions for their operations

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Data Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Solution Type outlook
    • 2.2.2. Deployment outlook
    • 2.2.3. End-User outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Manufacturing Execution System in Life Sciences Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing demand for personalized medicine
      • 3.2.1.2. Growth in pharmaceutical and biotechnology sector
      • 3.2.1.3. Technological advancements
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High implementation costs and complexity
  • 3.3. Manufacturing Execution System in Life Sciences Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Manufacturing Execution System in Life Sciences Market: Solution Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
  • 4.2. Segment Dashboard
  • 4.3. Manufacturing Execution System in Life Sciences Market Movement Analysis
  • 4.4. Manufacturing Execution System in Life Sciences Market Size & Trend Analysis, by Solution Type, 2018 to 2030 (USD Million)
    • 4.4.1. Software
      • 4.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 4.4.2. Services
      • 4.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Manufacturing Execution System in Life Sciences Market: Deployment Estimates & Trend Analysis

  • 5.1. Definitions and Scope
  • 5.2. Segment Dashboard
  • 5.3. Manufacturing Execution System in Life Sciences Market Movement Analysis
  • 5.4. Manufacturing Execution System in Life Sciences Market Size & Trend Analyses, by Deployment, 2018 to 2030 (USD Million)
    • 5.4.1. On-Premise
      • 5.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.2. Cloud/Web-based
      • 5.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 5.4.3. Hybrid
      • 5.4.3.1. Hybrid market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Manufacturing Execution System in Life Sciences Market: End-user Estimates & Trend Analysis

  • 6.1. Definitions and Scope
  • 6.2. Segment Dashboard
  • 6.3. Manufacturing Execution System in Life Sciences Market Movement Analysis
  • 6.4. Manufacturing Execution System in Life Sciences Market Size & Trend Analyses, by End-User, 2018 to 2030 (USD Million)
    • 6.4.1. Pharmaceutical and Biotechnology Companies
      • 6.4.1.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.2. Medical Device Companies
      • 6.4.2.1. Market estimates and forecast 2018 to 2030 (USD Million)
    • 6.4.3. Others (CDMOs, CROs, etc.)
      • 6.4.3.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Manufacturing Execution System in Life Sciences Market: Regional Estimates & Trend Analysis by Solution Type, Deployment, & End-User

  • 7.1. Regional Market Dashboard
  • 7.2. Global Regional Market Snapshot
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.4. North America
    • 7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. U.S.
      • 7.4.2.1. U.S. country dynamics
      • 7.4.2.2. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.4.3. Canada
      • 7.4.3.1. Canada country dynamics
      • 7.4.3.2. Canada market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. UK
      • 7.5.2.1. UK country dynamics
      • 7.5.2.2. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3. Germany
      • 7.5.3.1. Germany country dynamics
      • 7.5.3.2. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.4. France
      • 7.5.4.1. France country dynamics
      • 7.5.4.2. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.5. Italy
      • 7.5.5.1. Italy country dynamics
      • 7.5.5.2. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.6. Spain
      • 7.5.6.1. Spain country dynamics
      • 7.5.6.2. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.7. Norway
      • 7.5.7.1. Norway country dynamics
      • 7.5.7.2. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.8. Sweden
      • 7.5.8.1. Sweden
      • 7.5.8.2. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.9. Denmark
      • 7.5.9.1. Denmark
      • 7.5.9.2. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Japan
      • 7.6.2.1. Japan country dynamics
      • 7.6.2.2. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. China
      • 7.6.3.1. China country dynamics
      • 7.6.3.2. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4. India
      • 7.6.4.1. India country dynamics
      • 7.6.4.2. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Australia
      • 7.6.5.1. Australia country dynamics
      • 7.6.5.2. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.6. South Korea
      • 7.6.6.1. South Korea
      • 7.6.6.2. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.7. Thailand
      • 7.6.7.1. Thailand
      • 7.6.7.2. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Brazil
      • 7.7.2.1. Brazil
      • 7.7.2.2. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. Mexico
      • 7.7.3.1. Mexico
      • 7.7.3.2. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. Argentina
      • 7.7.4.1. Argentina country dynamics
      • 7.7.4.2. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. South Africa
      • 7.8.2.1. South Africa country dynamics
      • 7.8.2.2. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.3. Saudi Arabia
      • 7.8.3.1. Saudi Arabia country dynamics
      • 7.8.3.2. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.4. UAE
      • 7.8.4.1. UAE country dynamics
      • 7.8.4.2. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.5. Kuwait
      • 7.8.5.1. Kuwait country dynamics
      • 7.8.5.2. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. ABB
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Korber AG
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. MasterControl Solutions, Inc.
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. AVEVA Group Limited
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Cognizant
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Rockwell Automation
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. nagarro
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Siemens AG
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Emerson Electric Co.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. iBase-t
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America MES in life sciences market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 4 North America MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 5 North America MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 6 U.S. MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 7 U.S. MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 8 U.S. MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 9 Canada MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 10 Canada MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 11 Canada MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 12 Europe MES in life sciences market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 14 Europe MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 15 Europe MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 16 Germany MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 17 Germany MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 18 Germany MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 19 UK MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 20 UK MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 21 UK MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 22 France MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 23 France MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 24 France MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 25 Italy MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 26 Italy MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 27 Italy MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 28 Spain MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 29 Spain MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 30 Spain MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 31 Denmark MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 32 Denmark MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 33 Denmark MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 34 Sweden MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 35 Sweden MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 36 Sweden MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 37 Norway MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 38 Norway MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 39 Norway MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific MES in life sciences market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 44 China MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 45 China MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 46 China MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 47 Japan MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 48 Japan MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 49 Japan MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 50 India MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 51 India MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 52 India MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 53 South Korea MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 54 South Korea MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 55 South Korea MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 56 Australia MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 57 Australia MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 58 Australia MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 59 Thailand MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 60 Thailand MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 61 Thailand MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 62 Latin America MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 63 Latin America MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 64 Latin America MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 65 Brazil MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 66 Brazil MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 67 Brazil MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 68 Mexico MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 69 Mexico MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 70 Mexico MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 71 Argentina MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 72 Argentina MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 73 Argentina surgical ablation market, by end-user, 2018 - 2030 (USD Million)
  • Table 74 MEA MES in life sciences market, by region, 2018 - 2030 (USD Million)
  • Table 75 MEA MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 76 MEA MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 77 MEA MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 78 South Africa MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 79 South Africa MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 80 South Africa MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 81 Saudi Arabia MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 84 UAE MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 85 UAE MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 86 UAE MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 87 Kuwait MES in life sciences market, by solution type, 2018 - 2030 (USD Million)
  • Table 88 Kuwait MES in life sciences market, by deployment, 2018 - 2030 (USD Million)
  • Table 89 Kuwait MES in life sciences market, by end-user, 2018 - 2030 (USD Million)
  • Table 90 List of other players
  • Table 91 Participant's overview
  • Table 92 Financial per Deploymentance
  • Table 93 Key companies undergoing expansions
  • Table 94 Key companies undergoing acquisitions
  • Table 95 Key companies undergoing collaborations
  • Table 96 Key companies launching new components/services
  • Table 97 Key companies undergoing partnerships
  • Table 98 Key companies undertaking other strategies

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 MES in life sciences market: market outlook
  • Fig. 10 MES in life sciences competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 MES in life sciences market driver impact
  • Fig. 16 MES in life sciences market restraint impact
  • Fig. 17 MES in life sciences market strategic initiatives analysis
  • Fig. 18 MES in life sciences market: Solution Type movement analysis
  • Fig. 19 MES in life sciences market: Solution Type outlook and key takeaways
  • Fig. 20 Software market estimates and forecast, 2018 - 2030
  • Fig. 21 Services estimates and forecast, 2018 - 2030
  • Fig. 22 MES in life sciences market: deployment movement analysis
  • Fig. 23 MES in life sciences market: deployment outlook and key takeaways
  • Fig. 24 On-premise market estimates and forecast, 2018 - 2030
  • Fig. 25 Clou/Web-based market estimates and forecast,2018 - 2030
  • Fig. 26 Hybrid market estimates and forecast,2018 - 2030
  • Fig. 27 MES in life sciences market: end-user movement analysis
  • Fig. 28 MES in life sciences market: end-user outlook and key takeaways
  • Fig. 29 Pharmaceutical and biotechnology companies market estimates and forecast, 2018 - 2030
  • Fig. 30 Medical Device Companies market estimates and forecast,2018 - 2030
  • Fig. 31 Others market estimates and forecast, 2018 - 2030
  • Fig. 32 Global MES in life sciences market: regional movement analysis
  • Fig. 33 Global MES in life sciences market: regional outlook and key takeaways
  • Fig. 34 Global MES in life sciences market share and leading players
  • Fig. 35 North America market share and leading players
  • Fig. 36 Europe market share and leading players
  • Fig. 37 Asia Pacific market share and leading players
  • Fig. 38 Latin America market share and leading players
  • Fig. 39 Middle East & Africa market share and leading players
  • Fig. 40 North America: SWOT
  • Fig. 41 Europe SWOT
  • Fig. 42 Asia Pacific SWOT
  • Fig. 43 Latin America SWOT
  • Fig. 44 MEA SWOT
  • Fig. 45 North America, by country
  • Fig. 46 North America market estimates and forecast, 2018 - 2030
  • Fig. 47 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 48 Canada market estimates and forecast, 2018 - 2030
  • Fig. 49 Europe market estimates and forecast, 2018 - 2030
  • Fig. 50 UK market estimates and forecast, 2018 - 2030
  • Fig. 51 Germany market estimates and forecast, 2018 - 2030
  • Fig. 52 France market estimates and forecast, 2018 - 2030
  • Fig. 53 Italy market estimates and forecast, 2018 - 2030
  • Fig. 54 Spain market estimates and forecast, 2018 - 2030
  • Fig. 55 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 56 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 57 Norway market estimates and forecast, 2018 - 2030
  • Fig. 58 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 59 China market estimates and forecast, 2018 - 2030
  • Fig. 60 Japan market estimates and forecast, 2018 - 2030
  • Fig. 61 India market estimates and forecast, 2018 - 2030
  • Fig. 62 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 63 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 64 Australia market estimates and forecast, 2018 - 2030
  • Fig. 65 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 66 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 67 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 68 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 69 Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 70 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 71 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 72 UAE market estimates and forecast, 2018 - 2030
  • Fig. 73 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 74 Market share of key market players - MES in life sciences market